Competing Interests and Research Funding

Readers of Clinical Medicine and Pharmacology must be able to judge whether relationships outside a study could affect its design, interpretation or presentation. A disclosed relationship does not automatically make a paper ineligible. The responsibility is to provide enough relevant information for transparent assessment and to manage conflicts in editorial decisions.

What authors disclose

Each author reports financial and nonfinancial relationships relevant to the submitted work. These can include employment, consultancy, advisory roles, honoraria, travel support, stock or ownership interests, patents and patent applications, paid expert testimony, leadership in advocacy organisations, and close professional or personal relationships. Links to manufacturers of a studied drug, device or diagnostic test require disclosure even when payment is made to the author’s institution rather than to the author.

Funding and access to evidence

The manuscript identifies all research support, including grants, donated drugs, equipment, laboratory services, statistical assistance and medical writing. It states the funder’s role in study design, data collection, analysis, manuscript preparation and the decision to submit. Authors disclose restrictions on access to data or publication and identify who could inspect the complete study evidence. If there was no external funding, that fact is stated rather than leaving the funding field blank.

Collecting and publishing statements

The corresponding author collects a separate disclosure from every coauthor and provides a combined statement with the submission. Authors update it if a relationship changes before publication or a relevant omission becomes apparent. A statement that no interests exist should reflect the declarations of every author. The editor may request clarification, but disclosed commercial support alone is not a reason for rejection.

Editors reviewers and institutional relationships

Editors, guest editors and reviewers declare relationships that could impair impartiality before accepting responsibility for a paper. Recent collaboration, supervisory relationships, competition for the same product or a substantial financial interest can require recusal. CMP assigns an independent decision maker for work involving a member of its editorial team. Financial administrators deciding waivers or partner eligibility do not communicate an author’s ability to pay to reviewers.

Managing an omission

A report of an undisclosed interest should identify the article and the relevant relationship, with supporting evidence where available. The journal asks the affected person to respond, considers how the omission changes confidence in the study and decides whether disclosure, independent reassessment, a correction or further integrity action is needed. Retraction is not an automatic consequence of every incomplete declaration. Questions or supporting documents should be sent through the CMP editorial office at cmpeditorialoffice@jandoopress.com, identifying the manuscript number or article DOI where available.

Last updated: 17 September 2026